RAF413: GLP-1 Weight Loss Drugs – Wegovy, Ozembic, Zepbound and Others
On June 4, 2021, the FDA approved Wegovy for the treatment of chronic obesity and overweight individuals. Dr. John Sharretts, deputy director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research, said, “Today’s approval offers adults with obesity or overweight a beneficial new treatment option to…
Read More
Recent Comments